Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01778855 · ClinicalTrials.gov registry record · Phase 2
Hypothermia in Acute Stroke With Thrombolysis Imaging Evaluation of Revascularization
A Phase 2 study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT01778855 is a Phase 2 study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 6 participants.
The verdict
NCT01778855, a Phase 2 study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
The primary objective of this Phase 2 HASTIER study, as an ancillary study to ICTuS 2, is to compare key imaging measurements for serial changes in recanalization and reperfusion between hypothermia and normothermia treatment arms as intermediate outcomes of treatment effect. Secondary exploratory analyses include imaging of the neurovascular impact of reperfusion with hypothermia and tPA, including blood-brain barrier changes or permeability, hemorrhagic transformation, and infarct growth.
Interventions
- OTHER IV t-PA and normothermia
- DEVICE IV-tPA and hypothermia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-02 |
| Est. Completion | 2015-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01778855
The ClinicalTrials.gov registry entry for NCT01778855 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IV t-PA and normothermia is the first listed.
NCT01778855 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01778855 about?
NCT01778855 is a clinical study titled "Hypothermia in Acute Stroke With Thrombolysis Imaging Evaluation of Revascularization". The primary objective of this Phase 2 HASTIER study, as an ancillary study to ICTuS 2, is to compare key imaging measurements for serial changes in recanalization and reperfusion between hypothermia and normothermia treatment arms as intermediate outcomes of treatment effect. Secondary exploratory a...
What is the current status of trial NCT01778855?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2013-02. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01778855?
The interventions under investigation include: IV t-PA and normothermia (OTHER), IV-tPA and hypothermia (DEVICE).
Who is sponsoring clinical trial NCT01778855?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.